How to choose a white-label lab testing partner: 10 questions to ask
Launching a branded lab test looks simple from the outside: a box with your logo, a collection device, a results page. Behind it sits a regulated clinical laboratory, a kit supply chain and a data pipeline. Your customers will judge your brand by all three.
For supplement companies, DTC wellness brands and digital health startups, picking a white-label lab testing partner is one of the most consequential early decisions. Switching labs later means re-validating kits, rewriting reference ranges and migrating results. Here are 10 questions to settle first, and why each one matters.
1. Who actually performs the testing?
Some "white-label" offers are resellers or aggregators that route samples to whichever lab has capacity. Others are the lab itself. Neither model is wrong, but you should know which one you're buying.
Ask for the name, address and CLIA number of every lab that will touch your samples. Then ask what happens if that lab is at capacity. The answer tells you whether your results could come from different methods, instruments and reference ranges over time.
2. Is the lab CLIA-certified for these specific tests?
Under the Clinical Laboratory Improvement Amendments (CLIA), any facility that tests human specimens for health assessment, diagnosis or treatment needs a CLIA certificate. Certificates come in different types, and a lab certified only for waived tests can't run moderate- or high-complexity assays.
You don't have to take anyone's word for it. CMS's QCOR lookup lets you search a lab's CLIA certificate type and status. Do it before you sign.
3. Is the lab licensed where your customers live?
CLIA is the federal floor. Some states add their own rules. New York is the best-known example: any lab testing specimens collected in New York, wherever the lab is located, must hold a New York State clinical laboratory permit. Several other states have their own lab licensing rules, too.
If you plan to sell nationally, ask the lab for a written list of states where it can accept specimens. Then make sure your checkout blocks shipping where it can't.
4. Who orders the test?
Under CLIA, a lab may only perform testing at the written or electronic request of an authorized person, and state law decides who counts as authorized. In practice, many DTC programs rely on a physician network to review and order tests.
Clarify who provides that oversight, how abnormal or critical results are escalated, and who contacts the customer when a result needs follow-up. "The lab will handle it" isn't an answer.
5. Are the tests validated for at-home collection?
A test validated on a venous blood draw may not perform the same way on a finger-prick sample, a dried blood spot or a sample that spent two days in transit. Pre-analytical problems are the largest source of lab error. A widely cited review in Clinical Chemistry and Laboratory Medicine attributed 46–68.2% of total laboratory errors to the pre-analytical phase.
Ask for:
The specimen type each analyte is validated on
Stability limits for temperature and time in transit
The lab's sample rejection rate for home-collected kits, and what happens when a sample is rejected
6. Where does the regulatory landscape stand for lab-developed tests?
In 2024 FDA issued a rule that would have phased in oversight of lab-developed tests (LDTs). A federal court vacated that rule in March 2025, and FDA formally reverted its regulation in September 2025. For now, LDTs remain under CLIA oversight rather than FDA premarket review. New York still runs its own approval process for tests used on New York specimens.
Ask which of your tests are FDA-cleared or approved and which are LDTs. This affects what you can say in marketing and how you describe the test to customers.
7. Who builds, stores and ships the kits?
Kits have more moving parts than they look: collection devices, lot numbers, expiration dates, instructions, requisitions and return packaging. When the kit builder, the warehouse and the lab are separate companies, mismatches happen. A kit ships with the wrong tube, or a sample arrives at a lab that wasn't expecting it.
Questions to ask:
Who assembles custom white-label test kits, and to whose specimen specifications?
How are expiring components tracked and rotated?
Is return shipping included and pre-addressed to the testing lab?
Can you see a kit's status from packing to result?
8. How do orders and results move between systems?
Your platform needs orders to flow out and results to flow back without manual re-entry. Ask whether the lab offers an API, EMR connections or a partner portal, and how results are formatted. Structured, discrete values are much easier to chart and trend than PDFs.
Also ask about patient access. CLIA rules let labs give completed test reports directly to patients on request, so plan for how your results experience and the lab's obligations fit together. If you're comparing options, a lab's integration options page is a good place to start.
9. Who is responsible for health data privacy?
Whether HIPAA applies depends on who's involved and in what role. A clinical lab that bills electronically is typically a covered entity. A DTC wellness app often isn't. That doesn't mean it's unregulated. The FTC's Health Breach Notification Rule, updated in 2024, makes clear that it covers many health apps and similar technologies outside HIPAA, which must notify customers and the FTC after a breach. That includes unauthorized sharing of health data, not just hacks.
Map out who holds which data, which rules apply to each party, and what your contracts say about breach notice and data use.
10. Will your marketing claims hold up?
This one is about your side of the partnership. Supplement and wellness brands often want to connect test results to products, for example "low vitamin D? Try our formula." The FTC's Health Products Compliance Guidance says health benefit claims need competent and reliable scientific evidence, generally randomized controlled human trials.
A lab partner can't substantiate product claims for you. A good one will help you describe what a test does and doesn't measure. If you're building a test-and-recommend model, see how lab testing for supplement brands typically separates testing from product messaging.
A quick scorecard
Before you sign, you should be able to write down:
The CLIA number and license list of every testing lab
Who orders tests and handles abnormal results
Validation data for each specimen type you'll ship
Which tests are LDTs and which are FDA-cleared or approved
Who builds, stores and ships kits, and how returns work
How orders, results and patient access flow through your stack
Which privacy rules apply to each party
Who reviews your marketing claims
The bottom line
The best white-label partnerships feel invisible to customers because the hard parts were settled before launch. If you're comparing partners, IHDLab is a CLIA-certified lab (05D2040304) licensed in California, New York and Maryland. Whoever you choose, ask all 10.
This article is for general information and isn't legal, regulatory or medical advice. Talk to qualified counsel about your specific program.
